Amphotericin B is a polyene antifungal drug, often used intravenously for systemic fungal infections. It was originally extracted from Streptomyces nodosus, a filamentousbacterium, in 1955 at the Squibb Institute for Medical Research from cultures of an undescribed streptomycete isolated from the soil collected in the Orinoco River region of Venezuela. 
Its name originates from the chemical's amphoteric properties. Two amphotericins, amphotericin A and amphotericin B are known, but only B is used clinically, because it is significantly more activein vivo. Amphotericin A is almost identical to amphotericin B (having a double C=C bond between the 27th and 28th carbons), but has little antifungal activity.
Currently, the drug is available as plain amphotericin B, as a cholesteryl sulfate complex (ABCD), as a lipid complex (ABLC), and as a liposomal formulation (LAmB). The latter formulations have been developed to improve tolerability for the patient, but may show considerably different pharmacokinetic characteristics compared to plain amphotericin B.

Wuhan Biocar Pharmaceutical Co., Ltd. is a high-tech innovative enterprise specializing in the R&D, production and sales of APIs and pharmaceutical intermediates (excluding drugs). Our company is based in Optics Valley Bio-City, leverages the Wuhan University scientific research laboratory, makes full use of the advantages of the park policy, and focuses on the research and development of biomedicine. Our company has always been adhering to the business philosophy of "market demand as the guide; technology research and development as the core competitiveness; e-commerce as the platform" to be more accurate, faster, and more reliable as the best pharmaceutical units, university scientific research institutions, Hospital clinics, reagent units, and distributors provide biomedical products.

Shipping Advise: